Sergey Khomeriki

Combined therapy with adalimumab and mesenchymal stromal cells contributes to reduction in the degree of inflammation in ulcerative colitis

BACKGROUND: One of the new promising methods of treatment of patients with ulcerative colitis (UC) is biological therapy using bone marrow mesenchymal stromal cells (MCS).

Marina Chernova ;

Oleg Knyazev ;

Sergey Khomeriki ;

Dmitriy Kulakov ;

Anna Kagramanova ;

Anatoliy Konoplyannikov ;

Albina Lishchinskaya ;

Asfold Parfenov ;

Mariya Zvyaglova ;

11/20/2018

P006 The Relationship of Histological Remission With the Duration of the Anamnesis Ulcerative Colitis

BACKGROUND: The objectives of the treatment of patients with ulcerative colitis (UC) in accordance with the STRIDE-I provision, involves endoscopic healing of the colon mucosa...

Oleg Knyazev ;

Karina Noscova ;

Sergey Khomeriki ;

Irina Li ;

Tatyana Shkurko ;

Anna Kagramanova ;

Albina Lishchinskaya ;

Asfold Parfenov ;

12/15/2021